George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 189,346 shares at $38.57 ($7.3M) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($7.3M) by EVP, Investments & CLO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.57 | 79,346 | $3.1M | 41.9% |
| 2 | $38.57 | 79,346 | $3.1M | 41.9% |
| 3 | $38.50 | 30,654 | $1.2M | 16.2% |
| Total | $38.56 avg | 189,346 | $7.3M | 100% |
| Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |
| RPRX | SELL | 2023-02-27 | $1.9M | — | Filing → |